According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

A new, small cancer study may give hope to patients with solid tumors in the stomach, esophagus or rectum. The standard ...

Hoag is proud to announce that after a competitive national recruitment effort, Steven Grossman, M.D., Ph.D. has joined as ...

Hoag Memorial Hospital Presbyterian has named a renowned expert specializing in gastrointestinal cancer as the new executive ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

Gastroenterologists are uniquely positioned to expand their critical role in detecting and treating gastrointestinal diseases ...

New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure – – Combination of ziftomenib and imatinib shows robust and ...

The Uganda Cancer Institute (UCI) offers a range of treatment modalities for gastric cancer. Chemotherapy, which uses drugs ...